Two functional reticulocyte binding-like (RBL) invasion ligands of zoonotic Plasmodium knowlesi exhibit differential adhesion to monkey and human erythrocytes by Amma A Semenya et al.
Semenya et al. Malaria Journal 2012, 11:228
http://www.malariajournal.com/content/11/1/228RESEARCH Open AccessTwo functional reticulocyte binding-like (RBL)
invasion ligands of zoonotic Plasmodium knowlesi
exhibit differential adhesion to monkey and
human erythrocytes
Amma A Semenya1,4, Tuan M Tran1,5, Esmeralda VS Meyer1, John W Barnwell2 and Mary R Galinski1,3*Abstract
Background: Plasmodium knowlesi is a monkey malaria species that is becoming a serious public health concern
infecting hundreds and perhaps thousands of humans in Southeast Asia. Invasion of erythrocytes by merozoites
entails a cascade of molecular interactions. One step involves the adhesion of Plasmodium reticulocyte binding-like
(RBL) proteins. Plasmodium knowlesi merozoites express only two RBL invasion ligands, known as Normocyte
Binding Proteins (PkNBPXa and PkNBPXb).
Methods: Overlapping N-terminal regions of PkNBPXa and PkNBPXb were expressed in COS7 cells and tested for
surface expression and adhesion to rhesus monkey erythrocytes. Subsequent tests to study specific receptor ligand
interactions included adhesion to a panel of human and non-human primate erythrocytes, enzymatic treatment,
and site directed mutagenesis.
Results: An N-terminal cysteine-rich region of PkNBPXb (PkNBPXb-II) exhibited specific adhesion to rhesus monkey
erythrocytes. Mutation of four of five cysteines in PkNBPXb-II interfered with its surface expression on COS7 cells,
suggesting disulphide bond conformation is critical for intracellular trafficking. Binding of PkNBPXb-II was abolished
when rhesus erythrocytes were pre-treated with chymotrypsin, but not trypsin or neuraminidase. PkNBPXb-II also
bound other Old World monkey species and gibbon erythrocytes. However, erythrocytes from other primate
species including humans did not bind to PkNBPXb-II or native PkNBPXb. Importantly, unlike PkNBPXb, PkNBPXa
bound human erythrocytes, and this binding was independent of the Duffy blood group determinant.
Conclusions: The data reported here begins to clarify the functional domains of the P. knowlesi RBLs. A binding
domain has been identified and characterized in PkNBPXb. Notably, this study demonstrates that unlike PkNBPXb,
PkNBPXa can bind to human erythrocytes, suggesting that PkNBPXa may function as a ligand to enable the
invasion of P. knowlesi merozoites into human cells.
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Malaria is an ancient disease that continues to affect
several hundred million people annually in countries
of Africa, Asia, and South and Central America. Four
species of protozoan parasites of the genus Plasmo-
dium, Plasmodium falciparum, Plasmodium vivax,
Plasmodium ovale and Plasmodium malariae, have
long been known to cause the disease with most of the
nearly one million malaria-associated deaths attributable
to P. falciparum [1]. In the last decade, a fifth species,
Plasmodium knowlesi, a well-known cause of monkey
malaria, has emerged as a potential cause of severe and
fatal malaria in humans with more than 700 documented
cases [2-5]; unreported cases are likely to be in the thou-
sands in Southeast Asia.
As obligate, intracellular parasites, Plasmodium uti-
lizes various strategies to efficiently gain entry into host
erythrocytes and evade host immune responses, thereby
achieving the ability to replicate and survive. The asex-
ual erythrocytic stage of the Plasmodium life cycle is the
cause of all clinical symptomology of malaria, and suc-
cessful merozoite invasion is essential for the mainten-
ance of a malaria infection and propagation of the
parasites. An improved understanding of these processes
is important for devising prophylactic and therapeutic
strategies against the various species that cause human
malaria.
Plasmodium knowlesi has traditionally been instru-
mental as a model parasite species in studies of erythro-
cyte invasion and has served as a stringent model for
pre-clinical, proof-of-principle blood-stage malaria vac-
cine testing in rhesus monkeys [5-10]. Like P. falcip-
arum, and in contrast to P. vivax, P. knowlesi merozoites
are not restricted to invading reticulocytes but also in-
vade mature erythrocytes. Merozoite invasion is a com-
plex, multi-component process, involving a series of
parasite-host molecular interactions that are not com-
pletely defined. In studies using P. knowlesi, after initial
steps of surface adhesion, apical reorientation and host
cell selection, the merozoite forms an irreversible
electron-dense tight junction with the membrane of its
target erythrocyte [11]. The Reticulocyte Binding
Protein-Like (RBL) superfamily of ligands expressed at
the apical end of merozoites has been implicated in the
attachment of the apical end of this invasive stage to the
surface of erythrocytes and its commitment to entering
the selected host cell [10,12-14].
Two Reticulocyte Binding Proteins (RBP-1 and RBP-2),
from which the RBL name is derived, were originally
defined in P. vivax and shown to be expressed late in
schizogony as large proteins (>300 kDa) that specifically
bound to reticulocyte host cells [12]. Up to 10 paralo-
gous rbl genes have since been identified in the P. vivax
genome [15], a number of which have frameshiftmutations or are incomplete gene fragments and may be
non-functional pseudogenes (Meyer, Galinski, Barnwell,
unpublished data). Based on initial RBP binding data
[12] and parasite biology, the RBLs have been predicted
to be critical in the initial selection and apical attach-
ment of a merozoite to a potential host cell leading to a
commitment to invasion by the subsequent release of
Duffy Binding-Like/Erythrocyte Binding-Like (DBL/EBL)
invasion ligand proteins from the microneme organelles
and the formation of a tight junction [12,16].
A family of six paralogous rbl genes are now recog-
nized in the human malaria species P. falciparum [17],
six in the chimpanzee parasite, Plasmodium reichenowi
[18], two in P. knowlesi [19,20], at least two in Plasmo-
dium cynomolgi (also a simian malaria species) [19,20],
and 14 in the rodent parasite Plasmodium yoelii [21].
The two rbl genes characterized so far in P. cynomolgi
are orthologous to rbp-1 and rbp-2 of P. vivax [19]. It is
likely there will be other rbl genes identified in P. cyno-
molgi, as in P. vivax, but this remains to be determined
with the completion of genome sequences for this kin-
dred species.
Studies on the RBL ligands in P. falciparum, also
known as the reticulocyte binding protein homologs or
Rh proteins, have been extensive in recent years, with
these in mind as vaccine candidates [17]. Putative
erythrocyte binding domains have been reported to date
within the five expressed P. falciparum RBL proteins,
PfRh1, PfRh2a, PfRh2b, PfRh4 and PfRh5 [22-26]. Gen-
etic manipulation and invasion assays aiming to study
the function of the various Rh paralogs have also given
rise to the hypothesis that like the EBL invasion ligands,
the RBL family may present alternative invasion path-
ways for P. falciparum parasites [27,28].
This study specifically sought to investigate the RBLs
using P. knowlesi to better understand their role as
adhesins in the intricate process of erythrocyte invasion,
and their potential as a target for vaccine development.
This laboratory has previously reported the identifica-
tion of two intact rbl genes in P. knowlesi, and showed
that they become expressed in the microneme orga-
nelles as large proteins of approximately 300 kDa; a
small relic pseudogene orthologous to rbp-1 of P. vivax
was also confirmed in this species [20]. The P. knowlesi
RBLs were named as normocyte binding proteins,
PkNBPXa and PkNBPXb, and it was confirmed that
both these proteins adhere to rhesus RBCs in traditional
erythrocyte binding assays [20]. Immuno-electron mi-
croscopy further showed that the P. knowlesi RBLs ap-
pear to be released as merozoites attach to and invade
erythrocytes [20]. Given the limited number of only two
functioning rbl family members confirmed in the P.
knowlesi genome, and predictably the restricted poten-
tial for alternative RBL invasion pathways, it was
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binding domains, could serve as effective immunogens
for pre-clinical, proof-of-principle efficacy studies in
rhesus monkeys.
In the current study, the functional adhesive character-
istics of overlapping N-terminal P. knowlesi RBL sub-
domains were explored to identify potential domains
critical for ligand adhesion to erythrocytes. An
erythrocyte-binding domain was identified near the N-
terminus of PkNBPXb in a region with closely spaced
cysteines. Importantly, native PkNBPXb did not bind to
human erythrocytes, but the PkNBPXa ligand did bind
to human cells. These and associated data begin to de-
fine the ligand-receptor pathways for host specificity of
P. knowlesi in human and non-human primate hosts.
Methods
Cloning of pknbpxa and pknbpxb gene segments
Segments of pknbpxa and pknbpxb were amplified using
gene-specific primers and standard polymerase chain re-
action (PCR) conditions (Additional file 1), and cloned
into the pDisplay vector (Invitrogen, Carlsbad, CA).
Positive clones were identified and sequenced using the
ABI Prism BigDye Terminator Cycle Sequencing v3.1
Ready Reaction Kit (Applied Biosystems, Carlsbad, CA).
COS7 mammalian cell line transfections
COS7 cells were cultured in DMEM containing 10 %
Fetal Bovine Serum, HEPES buffer, and antibiotics at
37 °C in 5 % CO2. For transfections, using 1 μg of vector
DNA and Lipofectamine 2000 Reagent (Invitrogen,
Carlsbad, CA), the cells were plated in six-well plates at
1x105 cells per well using medium without antibiotics
and grown for 24 hours at 37 °C in 5 % CO2.
Lysis of COS7 cells and immunoblots
Twenty-four hours after transfection, cells were lysed
using CelLyticTM M (Sigma-Aldrich, St. Louis, MO).
Lysed cells containing expressed recombinant protein
were electrophoresed on 10 % polyacrylamide gels (Bio-
Rad, Hercules, CA) and transferred to nitrocellulose
membranes (Schleicher & Schuell, Keene, NH). The
membranes were probed with a mouse monoclonal anti-
body against c-myc or hemagglutinin domains (Invitro-
gen, Carlsbad, CA) for one hour followed by washes and
incubation with the secondary antibody anti-mouse IgG
conjugated to alkaline phosphatase (Promega, Fitchburg,
WI) for one hour. NBT/BCIP substrate (Promega, Fitch-
burg, WI) was added to the membranes to detect the
protein bands.
Erythrocyte samples
Erythrocytes were obtained from fresh whole blood or
cryopreserved samples. Blood from rhesus macaques,Macaca mulatta (Indian and Chinese origin), long-tailed
macaques (Macaca fascicularis), pigtail macaques
(Macaca nemestrina), sooty mangabeys (Cercocebus
atys) and white mice was collected at the Yerkes Na-
tional Primate Research Center (YNPRC) in tubes con-
taining ACD or CPDA. Blood from owl monkeys (Aotus
nancymaae) and squirrel monkeys (Saimiri boliviensis)
was collected in heparinized tubes at the Centers for
Disease Control and Prevention and YNPRC. Rabbit
blood collected in ACD was obtained from Covance
(Denver, PA). Primate blood cryopreserved in Glycero-
lyte 57 (Baxter Healthcare, Fenwal Div., Deerfield, IL)
[29,30] from marmosets (Callithrix jacchus), tamarins
(Saguinus midas), capuchins (Cebus apella), gibbons
(Hylobates lar), chimpanzees (Pan troglodytes), and
humans (Homo sapiens) (Duffy positive, Fya+b+; and
Duffy negative, Fya-b-) was thawed and washed with
RPMI media using standard procedures. All freshly drawn
blood and thawed cryopreserved blood were stored at 4 °C
for a maximum of seven days. All procedures were in
accordance with protocols approved by the respective
Institutional Animal Care and Use Committees.
Immunofluorescence assays (IFA)
Temporal expression curves were developed to deter-
mine the optimal time for surface expression of each re-
combinant construct. Briefly, COS7 cells were incubated
with mouse anti-HA antibody (Millipore, Billerica, MA)
diluted 1:250 for one hour and then washed twice in
DPBS. Cells were incubated with an Alexa Fluor 488
conjugated anti-mouse IgG antibody (Invitrogen, Carls-
bad, CA) diluted 1:200 for one hour and then washed
twice in DPBS. COS7 cells were fixed using 1 % formal-
dehyde for 10 minutes at room temperature. The per-
cent of cells expressing protein on the surface was
determined by counting the number of nuclei and the
number of cells emitting surface fluorescence by micro-
scopic analysis. Images were visualized using a Nikon
ECLIPSE TE 300 inverted microscope with 200x
magnification.
Erythrocyte rosetting assays
COS7 cells expressing each domain were washed with
complete culture media between 24 and 36 hours after
transfection, when surface expression was considered
optimal. The cells were incubated with rotational mixing
for at least two hours at room temperature with 0.2 %
erythrocytes in complete culture media. The cells were
washed three times with DPBS, incubated with 1 % for-
maldehyde for 10 minutes at room temperature to
stabilize rosettes, and then incubated with 0.1 μg/mL of
Hoescht dye (Invitrogen, Carlsbad, CA) for five minutes.
Erythrocyte adhesion was analysed by counting 350 cells
per field in 50 fields using a Nikon ECLIPSE TE300
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was scored as positive when most of a COS7 cell was
covered by erythrocytes. The paired t-test was used to
determine differences between the number of rosettes
formed by the different transfectants. P values less than
0.05 were considered significant. Relative binding was
calculated as a ratio between the number of rosette-
forming erythrocytes from each host cell and the num-
ber of rosette-forming erythrocytes from rhesus cells.
Enzymatic treatment of erythrocytes
Fifty microliters of packed rhesus erythrocytes were
incubated in 1 mL RPMI with 1 mg/mL trypsin (Calbio-
chem, Darmstadt, Germany), 1 mg/mL chymotrypsin
(Calbiochem, Darmstadt, Germany), or 0.025U/mL
neuraminidase (Roche, Penzberg, Germany) for one
hour at 37 °C. The cells were washed twice with RPMI
and incubated with 0.5 mg/mL soybean trypsin inhibitor
(Calbiochem, Darmstadt, Germany) or 1 mM phenyl-
methylsulfonyl fluoride, PMSF (Sigma-Aldrich, St. Louis,
MO) for 15 minutes at room temperature. The cells
were washed twice with RPMI and subsequently used in
erythrocyte adhesion assays.
Erythrocyte binding assays (EBAs)
P. knowlesi (H strain)-infected cells and supernatants
were obtained from either in vitro-adapted culture main-
tained with rhesus cells or ex vivo from an infected rhe-
sus macaque. Plasmodium knowlesi schizonts with
predominantly two to four nuclei were purified by cen-
trifugation on Percoll (Amersham, Little Chalfont, UK)
gradients >95 % homogeneity [31], placed in tissue cul-
ture flasks at a concentration of 2.5 × 107 parasites/mL
and matured to segmented schizonts. After their rupture
and release of merozoites in the absence of fresh ery-
throcytes, the culture media were centrifuged and super-
natants containing native parasite proteins stored in
liquid nitrogen. To perform EBAs, the supernatants were
incubated with 1x109 fresh erythrocytes, rotating at
room temperature for four hours. The cells were washed
twice by centrifugation through a Dow Corning 550 fluid
(Dow Corning Corporation, Midland, MI) cushion.
Bound proteins were eluted in 50 μl of 5x RPMI at room
temperature and harvested by centrifugation at 4 °C for
10 minutes at 7,500 rpm. The eluted proteins were sub-
jected to SDS-PAGE through 5 % gels (Bio-Rad,
Hercules, CA), transferred to nitrocellulose membranes
(Schleicher & Schuell, Keene, NH), and probed with
rabbit polyclonal antisera to PkNBPXa or PkNBPXb for
two hours followed by alkaline phosphatase conjugated
anti-rabbit IgG (Promega, Fitchburg, WI) for one hour.
Protein bands were visualized by adding NBT/BCIP sub-
strate (Promega, Fitchburg, WI) to the membranes. Test
rabbit antisera included anti-PkNBPXa, anti-PkNBPXband P. knowlesi Merozoite Surface Protein (140 kDa)
antiserum described previously [20].
Site-directed mutagenesis
Five clones were generated with mutated cysteines
(Cys193Gly, Cys254Gly, Cys298Gly, Cys326Gly, and
Cys332Gly) using the QuickChange Multi Site Directed
Mutagenesis Kit (Stratagene, La Jolla, CA). Primers were
designed according to the manufacturer’s suggestion
(Additional file 2). DNA from pDisplay-PkNBPXb-RII
was used as a template for the mutagenic PCRs. Positive
clones were identified and sequenced using a BigDye
Terminator Cycle Sequencing v3.1 Ready Reaction Kit
on a 3100 Genetic Analyzer (Applied Biosystems, Carls-
bad, CA). The resulting sequences were analysed using
MacVectorTM 7.2.2 (Accelrys Software Inc., San Diego,
CA) to ensure the presence of mutated sites. COS7 cells
were transfected with clones representing each mutation
to evaluate surface fluorescence and binding to erythro-
cytes. A time course was developed to determine the op-
timal time of surface expression. The relative binding
ratio was established using average data from five bind-
ing experiments.
Results
An N-terminal region of PkNBPXb binds to rhesus
monkey erythrocytes
Three segments from the beginning of the P. knowlesi
nbpxa gene and eight encompassing the 5′ half of the P.
knowlesi nbpxb gene were cloned into the pDisplay vec-
tor (Figure 1A). Each segment of approximately 1 kb,
encodes about 350 amino acids, and contiguous frag-
ments overlap by about 165 amino acids. Protein was
expressed by all eight pknbpxb constructs (Figure 1B)
and surface fluorescence was monitored using anti-HA
specific antibody on intact COS7 cells. Seven of the
pknbpxb constructs were expressed at the surface, al-
though at different levels as judged by fluorescent and
immunoblot intensities (Table 1). The one exception was
Region III, which despite repeated attempts was not
expressed at the surface. Surface expression was moni-
tored by IFA approximately every three hours between
18 and 36 hours after transfections, and optimal expres-
sion was between 33 and 36 hours. The relative differ-
ences in surface expression observed correlated with the
differences observed when comparing the total protein
expression profiles (Table 1; Figure 1B). In contrast with
the expression of different regions of PkNBPXb in pDis-
play, attempts to achieve similar results with PkNBPXa
clones were unsuccessful. Anti-HA specific IFAs on in-
tact COS7 cells indicated that none of the three cloned
fragments of pknbpxa displayed protein on the surface
(data not shown), although there was internal expression
of each construct in COS7 cells.
Figure 1 Expression of pknbp gene segments in COS7 cells and binding profile to rhesus erythrocytes. (A) Three regions spanning the 5′
end of the coding region of PkNBPXa were cloned into pDisplay as overlapping 500 nucleotide gene segments. The numbers listed correspond
to the amino acid positions delineating a particular expressed gene segment. Though the recombinant proteins were expressed intracellularly,
they never reached the surface of the COS7 cells (data not shown). Eight recombinant segments (Regions I - VIII) spanning the N-terminal half of
PkNBPXb were cloned and expressed in COS7 cells. (B) Protein expression for each COS7/PkNBPXb region was evaluated by immunoblot using a
specific antibody against the c-myc tag encoded in the C-terminus of the pDisplay vector. (C) Rhesus monkey erythrocytes were found to adhere
only to PkNBPXb-II forming a large rosette pattern on the surface of COS7 cells. Panels 1 and 2 show images representing nuclear staining with
Hoechst dye, COS7 cell protein expression detected by anti-HA and Alexa Fluor 488-labeled anti-mouse IgG, and erythrocyte rosetting assay
results, respectively. Top and bottom panels show the surface expression and binding capability of Region II and Region VIII, respectively. Region
VIII showed high expression by immunoblot while displaying no binding affinity to rhesus erythrocytes. Images were captured at room
temperature using a Nikon ECLIPSE TE 300 inverted microscope using the Plan Fluor ELWD 40x / 0.45 aperture and 10x magnification eye piece
and analysed using the Diagnostic Instrument, Inc. software.
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formed to test the ability of the seven distinct regions of
PkNBPXb to bind rhesus erythrocytes. Five separate
experiments demonstrated consistently robust rhesus
erythrocyte rosette formation with Region II, while no
rosettes were detected with any other regions (Table 1).
The rosettes provided a clear indication of binding, with
numerous erythrocytes covering the surface of the COS7
cells transfected with the pknbpxb-II construct. The spe-
cificity of this observation was examined by demonstrat-
ing that rhesus monkey erythrocytes adhered only to
COS7 cells that specifically exhibited surface expression
of the PkNBPXb-II protein (Figure 1C, panel 1).Additionally, other segments of PkNBPXb that displayed
relatively higher levels of protein expression at the sur-
face of COS7 cells did not bind any rhesus monkey ery-
throcytes (Figure 1C, panel 2).
PkNBPXb-II demonstrates binding to erythrocytes from
several primate species, particularly Old World monkeys
and the Lesser Apes of Southeast Asia
Erythrocytes from a panel of primate species, mice, and
rabbits were also tested for their ability to bind to COS7
cells expressing PkNBPXb-II, with clear distinctions
(Table 2). The binding levels were averaged over several
experiments and quantitatively presented in Table 2.
Table 1 Comparison of the expression of overlapping
regions of PkNBPXb at the surface of COS7 cells
Region of
PkNBPXb
% of cells with surface
protein expression




I 1.1 % +/− 0.6 % −
II * 3.8 % +/− 1.3 % +
III ** 0 N/A
IV 0.6 % +/− 0.4 % −
V 1.8 % +/− 0.9 % −
VI 1.2 % +/− 0.6 % −
VII 7.3 % +/− 3.7 % −
VIII 11.5 % +/− 2.2 % −
* Average number of rosettes for region II observed in fifty fields = 93.
** Surface expression was not observed in three separate experiments for this
region.
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family Cercophithidae consistently bound to PkNBPXb-
II. There were no significant differences in binding
observed between rhesus erythrocytes of Indian or
Chinese origin (data not shown), or between erythro-
cytes from M. nemestrina, a natural host of P. knowlesi.
However, erythrocytes from the primary natural host,
M. fascicularis (p< 0.01), and the sooty mangabey
monkey (p< 0.001) bound PkNBPXb-II expressing
COS7 cells on average 4.3 times higher than rhesus
monkey erythrocytes (Table 2). Surprisingly, PkNBPXb-
II expressing COS7 cells also demonstrated rosette for-
mation with erythrocytes from gibbons, a Lesser Ape
from Southeast Asia, which was two-fold greater than
for rhesus erythrocytes. This increase in binding ofTable 2 Binding profile of erythrocytes from various primate
cells
Common Name Scientific Name Regional Classification
Rhesus Macaque Macaca mulatta Old World
Long-tailed Macaque Macaca fascicularis Old World
Pigtail Macaque Macaca nemestrina Old World
Sooty Mangabey Cercocebus atys Old World
Owl Monkey Aotus nancymaae New World
Squirrel Monkey Saimiri boliviensis New World
Capuchin Cebus apella New World
Marmoset Callithrix jaccus New World
Tamarin Saguinus midas New World
Human Homo sapiens Great Apes
Chimpanzee Pan troglodytes Great Apes
Gibbon Hylobates lar Lesser Apes
Rabbit Oryctolagus cuniculus Rabbit
Mouse Mus musculus Mouse
*Mean number and standard deviation of COS7 cells with surface bound rosettes ogibbon compared to rhesus erythrocytes is statistically
significant (p< 0.02). Erythrocytes from humans and
chimpanzees did not adhere and form rosettes in these
assays. Erythrocytes from New World primate species
either bound weakly (tamarins) or showed no binding
(owl, squirrel, marmoset and capuchin monkeys). Rela-
tively weak binding was also observed when COS7 cells
expressing PkNBPXb-II were tested in the rosetting
assays using rabbit erythrocytes, but mouse cells did
not bind.
Chymotryspin treatment of rhesus erythrocytes prevents
adhesion to PkNBPXb-II, but not the native protein,
PkNBPXb
Rhesus monkey erythrocytes treated with chymotrypsin,
neuraminidase, or trypsin were tested in the erythrocyte
adhesion (rosetting) assays to determine basic features of
the receptor(s) involved in the interaction of both, native
PkNBPXb and COS7-expressed PkNBPXb-II with ery-
throcytes. Pre-treatment of the erythrocytes with chymo-
trypsin nearly abrogated binding of the erythrocytes to
PkNBPXb-II (Figure 2A). The >90 % decrease in bind-
ing of chymotrypsin-treated erythrocytes is statistically
significant (p< 0.001) compared to untreated erythro-
cytes. In contrast, cells expressing PkNBPXb-II bound
trypsin and neuraminidase-treated erythrocytes greater
than erythrocytes that were not enzymatically treated.
This increased binding of trypsin and neuraminidase-
treated erythrocytes is significantly greater (p< 0.05)
than binding of untreated erythrocytes.
The chymotrypsin-sensitive profile of PkNBPXb-II ad-
hesion contrasts with the binding profile of the largely
intact native PkNBPXb to rhesus monkey erythrocytesand non-primate species to PkNBPXb-II expressing COS7
Geographical Range RBC* Rosettes rPkNBPXb-II Binding
India, China, Thailand 21.2+/−17.6 Yes
Southeast Asia 87.5+/−31.6 Yes
Southeast Asia 19.0+/−7.8 Yes
West Africa 85.0+/−42.7 Yes
South America 0.0 No
South America 0.0 No
South America 0.0 No
South America 0.0 No
South America 2.4+/−2.6 weak
Worldwide 0.0 No
West and Central Africa 0.0 No
Southeast Asia 49.6+/−31.4 Yes
4.1+/−6.6 weak
0.0 No
f erythrocytes per 50 fields of 40x objective.
AB C
Figure 2 Binding of PkNBPXb-II and native PkNBPXb to enzymatically treated rhesus monkey erythrocytes. (A) PkNBPXb-II cells were
tested for relative binding in adhesion (rosetting) assays to rhesus monkey erythrocytes that were either untreated, or treated with chymotrypsin
(CT), trypsin (T), or neuraminidase (NA), * p-value <0.05 and *** p-value <0.001. (B) Native PkNBPXb binding was tested in erythrocyte binding
assays with rhesus monkey erythrocytes that were untreated or treated with CT, T, or NA. Total supernatants (TS) and comparable eluates from
untreated rhesus monkey erythrocytes (R) incubated without supernatants were also applied to the SDS-PAGE gels and transferred to
nitrocellulose membranes. The immunoblot was probed with an anti-PkNBPXb antibody [20]. (C) A negative binding control was included using
duplicate aliquots of the RBC samples tested in B whereby anti-PkMSP3/140 antibody recognizes the native protein in the supernatant only.
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(Figure 2B). Rhesus erythrocytes were treated with neur-
aminidase, trypsin, or chymotrypsin, and eluates from
EBAs using these cells were probed in immunoblot
assays with a rabbit anti-PkNBPXb specific antibody
[20]. Protein bands >250 kDa, corresponding to the full-
length protein were observed in all samples that were
incubated with the culture supernatant (Figure 2B).
Interestingly, after testing supernatants in several experi-
ments, the immunoblot signal on neuraminidase-treated
and untreated rhesus cells incubated with the native
PkNBPXb was consistently stronger than trypsin- or
chymotrypsin-treated rhesus cells (not shown). No pro-
tein bands were detected with untreated rhesus erythro-
cytes incubated in the absence of culture supernatants.
As a control to judge the specificity of adhesion of these
cells to native PkNBPXb, the same samples were also
probed with an antibody against an abundant merozoite
surface protein (PkMSP3140) (Figure 2C). PkMSP3140 is
known to be present in culture supernatants, but it does
not adhere to the surface of rhesus erythrocytes [20].
When the samples were probed with the rabbit anti-
PkMSP3140 antibody, the native protein was only
detected in the supernatants.Four cysteine residues within PkNBPXb-II are critical for
surface expression on COS7 cells
The PkNBPXb-II recombinant protein contains five cyst-
eine residues (Cys193, Cys254, Cys298, Cys326, Cys332),
which were hypothesized to be critical in the formation
of the correct tertiary conformation of the binding do-
main. Alignment of the first 300–400 amino acids of
PkNBPXb-II, PkNBPXa, and the related RBL proteins in
P. vivax (RBP2) and P. falciparum (Rh2a/b) demon-
strated conservation of three of these cysteines
(Figure 3).
To determine which of these cysteines may be import-
ant for the formation of disulphide bonds and if they are
required for the adhesion of erythrocytes, site-directed
mutagenesis was performed to replace each of them with
glycine residues. Five mutated pknbpxb-II pDisplay con-
structs, confirmed by DNA sequencing, were tested for
protein surface expression every three hours from 18–36
hours after transfection. When Cys193 was mutated, pro-
tein surface expression was observed, albeit at reduced
levels. Rosetting of erythrocytes was also observed but
again at reduced levels (~90 %) (Figure 4). However, pro-
tein surface expression was not observed for the other
four mutated pknbpxb-II constructs (Cys254, Cys 298,
Figure 3 Amino acid alignment of the N-terminal regions of PkNBPXa, PkNBPXb, PvRBP2 and PfNBP2a. Alignment of the first 300–400
amino acids of the N-terminus of PkNBPXa, PkNBPXb, PvRBP2, and PfNBP2a demonstrates conservation of three cysteine residues among species.
These three residues in PkNBPXb correspond to Cys254, Cys298, and Cys332. Two other cysteine residues are also present in the N-terminus of
PkNBPXb-II and are Cys193 and Cys326.
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observed with cells transfected with these constructs
(Figure 4B). However, when these mutated constructs
were genetically manipulated again to encode cysteine in
place of the glycine residues, protein surface expression
and erythrocyte binding were restored (Figure 4).
Native PkNBPXa binds to human erythrocytes
The results above indicated that COS7 cells expressing
PkNBPXb-II do not form rosettes with human erythro-
cytes, going against what might be expected since P.
knowlesi is known to infect and cause malaria in humans
[4,5]. This study therefore investigated whether either or
both of the native proteins, PkNBPXa and PkNBPXb,
would bind to human erythrocytes in standard EBAs
[20]. Both Duffy positive (Fya+b+) and negative (Fya-b-)
human erythrocytes were incubated with P. knowlesi cul-
ture supernatants and the bound proteins were eluted,
processed through SDS-PAGE, blotted, and probed with
antibodies specific to either PkNBPXa or PkNBPXb [20].
This assay showed that only native PkNBPXa bound
human erythrocytes (Figure 5). As a negative control,and to support the binding specificity of PkNBPXa, the
same samples were probed with rabbit antiserum against
PkMSP3140. Samples containing culture supernatants
alone reacted with the PkMSP3140 antibodies, but not
the eluates from EBAs (data not shown). The inability of
the native PkNBPXb to bind human erythrocytes in
these assays is consistent with the data shown here dem-
onstrating that the PkNBPXb-II expressed at the surface
of COS7 cells did not bind to human erythrocytes. These
experiments also demonstrated that the native PkNBPXa
protein was able to bind to both Duffy positive and
Duffy negative RBCs in the erythrocyte binding assays
with similar intensities.
Discussion
Through COS7 cell surface expression and rosetting ad-
hesion assays, this study has identified an erythrocyte-
binding domain within the N-terminus of one of two P.
knowlesi RBL proteins, namely PkNBPXb. This binding
domain wase called PkNBPXb-II, because it was the sec-
ond in a series of eight overlapping protein constructs
tested. Using similar procedures, a comparable domain
Figure 4 Four disulphide bonds in PkNBPXb are important for
expression on the surface of COS cells. The N-terminal domain of
PkNBPXb contains five cysteine residues (C193, C254, C298, C326, C332).
Using site directed mutagenesis, all five residues were individually
mutated to glycine and all but C193 were found to be required for
binding to erythrocytes. The glycine residues present in each construct
were mutated back to cysteine residues; these constructs were able to
express protein on the surface and also able to bind erythrocytes.
Surface and internal expression is indicated with+or – signs.
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PkNBPXa. Importantly, however, the only other RBL lig-
and expressed by P. knowlesi merozoites, PkNBPXa, in
contrast with PkNBPXb, strongly binds human erythro-
cytes in addition to monkey host erythrocytes by trad-
itional EBAs.A B
Figure 5 PkNBPXa binds to Duffy negative and Duffy positive
human erythrocytes. Native PkNBPXa (A) and PkNBPXb (B) present
in parasite supernatants were tested for their ability to bind Duffy
positive and Duffy negative human cells by EBA. Culture
supernatants (S) containing soluble merozoite proteins were
incubated with human Duffy positive (Fya+b+) and Duffy negative
(Fya-b-) erythrocytes, and then the bound proteins were eluted,
electrophoresed and transferred to nitrocellulose membranes.
PkNBPXa and PkNBPXb specific antibodies were used to probe the
membranes. PkNBPXa was detected in the supernatants and eluates
from Duffy positive and Duffy negative erythrocytes. PkNBPXb was
present in the supernatant but did not bind to either type of human
erythrocytes. As a control, erythrocytes were incubated in the
absence of supernatants and no PkNBPXa specific bands were
detected in those samples (R).This study focused on the N-terminal half of the
PkNBPs [20] given certain intuitive considerations about
RBL structure and the exposure of binding sites, as well
as previous studies characterizing the binding domain of
PvRBP1 [32]. In addition, erythrocyte-binding domains
of P. falciparum and P. yoelii RBL family members have
since been identified in various N-terminally associated
regions [22,23,33].
PkNBPXb-II was the only domain found to bind ery-
throcytes. This domain includes amino acids 184 to 531,
contains five cysteines, and resides in the relatively
cysteine-rich N-terminal area designated as the Rh hom-
ology region in RBL paralogs in P. falciparum [23,25,34].
Interestingly, this region of low homology was first deli-
neated by clustal alignment of P. vivax RBP1 with Rh1
and Rh4 [23]. The binding domains for PfRH4 and
PfRH5 appear to reside in this zone of weak homology
based on the binding of recombinant peptides designed
from this region [23,25]. However, the binding domains
for two other P. falciparum family members, Rh1 and
Rh2a/Rh2b, apparently reside just outside this region of
Rh homology [22,24,26].
The RBL invasion ligand proteins contain a variable
number of cysteines in the N-terminal region of hom-
ology, but it has not been known if these residues par-
ticipate in disulphide bond conformation necessary for
receptor-ligand binding interactions. This study shows
that the mutation of four individual cysteine residues
prevented the trafficking to and expression of the
PkNBPXb-II protein on the surface of COS7 cells, sug-
gesting that cell-surface expression of PkNBPXb-II is
dependent on critical cysteine residues. Only the muta-
tion of Cys193 to Gly did not completely abolish the
binding of NBPXb-II to erythrocytes, but expression was
reduced along with a reduction of binding levels by 85
or 90 % as compared to cells expressing unaltered
NBPXb-II. Taken together the data suggest that cell-
surface expression of PkNBPXb-II is dependent on crit-
ical cysteine residues and this lack of trafficking to the
surface could indicate that disulphide formation is a
functionally important feature in this region of the
protein. Mutagenesis of amino acid residues has been
performed to map Plasmodium blood-stage parasite
binding domains in PfEMP1DBLβ-C2 [35] and PvDBP
[36,37]. Although functionally important cysteine-rich
regions have been predicted within the N-terminal
regions of PfRH1, PfRH2a/2b, PfRH4 and Py235
[23,24,33,38,39], there have been no studies conducted,
with mutations or otherwise, to show cysteine function-
ality in these ligands. The RBL N-terminal regions share
at least three conserved cysteines (Figure 3), and based
on this data it is reasonable to hypothesize that they
may be important for the conformational dependent
functions of some or all of the RBLs.
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cells can be useful to generate receptor profiles and de-
lineate potential receptors for particular binding pro-
teins. This study shows that chymotrypsin treatment of
rhesus erythrocytes abolished the formation of erythro-
cyte rosettes with PkNBPXb-II, but not trypsin or neur-
aminidase treatments. In contrast, adhesion of native
PkNBPXb to treated or untreated rhesus erythrocytes in
EBAs was positive, although binding was consistently
stronger with neuraminidase-treated or untreated cells.
These data indicate that PkNBPXb-II contains a binding
domain when tested in rosetting assays, yet the native
protein may have additional co-functional domains re-
sistant to enzyme treatment. Recently, ligand-binding
specificity has been studied in detail, including enzym-
atic cleavage profiles in PfRh2a/b a homolog of the
PkNBPs that suggest more than one binding domain in
a RBL invasion ligand [40].
Native PkNBPXb as well as the PkNBPXb-II domain
also has a host specific target cell binding preference. Na-
tive PkNBPXb in EBAs bound to rhesus monkey erythro-
cytes, but not to human erythrocytes, a result similar to
that of rosetting assays with PkNBPXb-II. PkNBPXb-II
robustly bound rhesus erythrocytes and even better when
the rosetting erythrocytes were from the primary monkey
host, M. fascicularis or mangabey and gibbon species.
However, this binding domain and native PkNBPXb did
not bind erythrocytes from humans, chimpanzees and
for the most part New World Monkeys.
Plasmodium knowlesi has emerged as an important
zoonotic human pathogen of increasing public health
significance [1,2,5,41]. A future focus on studying
PkNBPXa adhesion will be important because, in con-
trast to PkNBPXb, PkNBPXa not only binds to rhesus
erythrocytes in EBA assays [20], but also human erythro-
cytes (Figure 5). This study attempted to identify a
binding domain in PkNBPXa. However, while seven seg-
ments of PkNBPXb were readily cloned and expressed at
the surface of COS7 cells, comparable cloned segments
of PkNBPXa that are surface expressed have not yet
been developed, despite many attempts. Future attempts
to optimize both expression and trafficking of PkNBPXa
regions may include the adjustment of the boundaries of
these regions or changes in the expression vector, mam-
malian host cells, or expression conditions. Expanded
studies involving PkNBPXa adhesion to human and other
non-human primate erythrocytes will hopefully elucidate
the role of this protein, perhaps as the RBL ligand used
by P. knowlesi to naturally infect humans.
Interestingly, the host origin of erythrocytes correlates
to some degree with the binding specificities observed,
regardless of the actual ability of P. knowlesi to invade a
particular primate cell type. For example, PkNBPXb
binds strongly to erythrocytes from Old World monkeys(long-tailed, rhesus and pigtail macaques) with a South-
east Asian or African origin (sooty mangabeys) and to
Lesser Apes (gibbons), which also originate in Southeast
Asia, but not to erythrocytes from humans (or chimpan-
zees) or New World primates. Rosetting of macaque ery-
throcytes was expected because rhesus macaques are
utilized as an experimental model studying P. knowlesi
infections, and pigtail and long-tailed macaques are the
natural hosts for P. knowlesi. Less expected, because
human and chimp erythrocytes did not bind, was the
strong binding observed to gibbon erythrocytes. Gibbons
are neither natural nor normally experimental hosts for
P. knowlesi, but can be infected with this parasite. Al-
though New World monkeys, squirrel, owl and marmo-
set monkeys are known to be very susceptible to P.
knowlesi infection [42-44], erythrocytes from these spe-
cies did not form rosettes with PkNBPXb-II. Similarly,
and importantly, human erythrocytes did not bind
PkNBPXb-II or native NBPXb, even though P. knowlesi
does infect humans. Since PkNBPXa not only binds ery-
throcytes from Old World monkeys, but also erythro-
cytes from humans, this RBL ligand may play an
important role in allowing P. knowlesi to infect this host.
These observations are consistent with the necessity of
multiple receptor-ligand interactions being important to
achieve successful invasion of erythrocytes from a wide
range of hosts.Conclusions
This study has provided comparative data relevant for
understanding how RBLs interact with host erythrocytes.
It is well-established that P. knowlesi (H strain) infection
in rhesus macaques is a lethal infection unless treated
with anti-malarial drugs, but only recently has its clinical
significance in causing mild to severe and lethal infec-
tions in humans been appreciated [2-5,41,45]. The con-
tinued investigation of P. knowlesi in rhesus and other
macaques is now of direct relevance to humans. The
identification of the PkNBPXb-II erythrocyte binding
domain and differential binding specificities between
PkNBPXa and PkNBPXb are important steps towards
better understanding the role(s) of the RBL family of
merozoite invasion ligands in host selection and advan-
cing pre-clinical vaccine trials in rhesus macaques to de-
termine whether RBL domains can in fact elicit
efficacious protective immune responses.Additional files
Additional file 1: Primer sequences for regions cloned into pDisplay
vector.
Additional file 2: Primer sequences for site-directed mutagenesis of
PkNBPXb-II.
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